relationship is a major factor in the reluctance of many doctors to seek fully informed consent froui patients entering clinical trials9 or actually to participate in such trials." Our study did not show any difference for the two consent procedures in the doctor-patient relationship (as perceived by the patient), although because of the low power of the study an adverse effect cannot be ruled out.
In conclusion, our results clearly indicate some trade offs when patients are given all the relevant information compared with an individual approach to obtaining consent. Patients in the total disclosure group had a greater understanding of their treatment and of the research aspects of the trial but at the expense of increased anxiety. We hope that these results will stimulate similar controlled trials of consent practices at other hospitals, where the individual style of seeking consent may differ.
Introduction
Awareness of the high incidence of cardiovascular disease in Finland as a whole, and in North Karelia in particular,'4resulted in a comprehensive, community based preventive programme to control cardiovascular disease: the North Karelia project.' Its aim was to reduce mortality and morbidity from cardiovascular disease by reducing established r-isk factors, such as smoking, high serum cholesterol concentrations, and blood pressure, in the entire community. The ' Changes in mortality during the first 10 years of the project were also calculated as the difference between the average mortality during the period from 1969 to 1971-that is, before the start of the project-and the most recent three years during the 10 year follow up-that is, 1980 to 1982. Net decline in mortality in North Karelia was calcuated as the difference between these changes (absolute net decline).
As mortality from causes examined is higher in North Karelia than in the rest of the country comparisons based on relative changes (relative annual change) make differences in the province of North Karelia look smaller than in comparisons based on absolute changes (net decline and regression slope). BRITISH MEDICAL JOURNAL VOLUME 293 25 OCTOBER 1986 younger age groups of North Karelian women had reached the national average ( fig 2) . Figure 3 shows the age standardised annual mortality from ischaemic heart disease for men and women in North Karelia and the rest of Finland, and table I shows the average annual decrease in mortality from ischaemic heart disease. Figure 4 shows the age standardised annual mortality from cerebrovascular stroke for men and women in North Karelia and the rest of Finland, while table I shows the average annual decline in mortality from cerebrovascular stroke. Mortality from stroke in men in North Karelia varied considerably during the first part of the study. Only after 1976 did a steady and steep decline occur (fig 4) .
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Total mortality in North Karelia declined significantly among men and women. Among men this relative decline was no greater than that in the rest of Finland (table I) 
Discussion
In our earlier reports we have shown that mortality from ischaemic heart disease in North Karelian men started to decrease particularly steeply from 1974 onwards-that is, two years after the start of the North Karelia project. Preventive activities similar to the North Karelia project have gradually been launched nation wide, partly based on the experience gained from the project.
The linear trend for the entire period from 1969 to 1982 in our present analyses is a conservative evaluation of the trend in mortality in relation to the intervention programme, as the programme started only in 1972. The possible effect on the trend of the intervention programme is not taken into account in this analysis, which is based on linear trends. As can be seen in the analysis of stroke mortality among men, an analysis that takes into account the possible time lag between effects on risk factors and mortality would change the results in favour of North Karelia.
For Finland as a whole we found an average annual decline in mortality from ischaemic heart disease of about 2-0% in men and 3 0% in women. Mortality from stroke decreased annually by 4-4% in men and 6 0% in women, and mortality from cardiovascular disease decreased by 2-6% in men and 5 0% in women (table I) . In men these national decreases mostly took place during the last few years, later than in North Karelia. The decline in mortality from cardiovascular disease in Finland is now one of the steepest in the world. Annual declines ofthe same magnitude have been found only in Australia and the United States.'2-'6 The decrease in mortality from ischaemic heart disease in North Karelian men was significantly greater than that in the rest of the country. The present results support the earlier-finding that the decline in mortality from ischaemic heart disease in North Karelian men was especially great after 1974.9 In fact mortality from ischaemic heart disease in men in North Karelia decreased on average by 4-3% a year from 1974 to 1982.
Mortality from stroke in Finland, which used to be among the highest in Europe in the 1950s, has declined steeply.'7 During the 1970s the decline was particularly rapid, ranking with the decline in Japan as the fastest in the world.'7-'9 Owing to relatively few deaths from stroke in the age category 35 to 64 and the unreliability of the diagnostic classification in earlier years the annual mortality for individual provinces varied considerably. It was surprising that the mean mortality from stroke in Finland as a whole did not change much from 1979 to 1982. This stability may show that treatment for hypertension did not improve during those years in terms of either the number of treated patients or the effectiveness of antihypertensive drug treatment.'222 In North Karelian men mortality from stroke started to decline only in 1976, but the decrease since then has been very rapid-about 14% a year. The main improvements in hypertension control in North Karelian men took place from 1974 to 1977.21 22 We cannot explain why the decrease and difference in the decline in favour ofNorth Karelia among men started earlier for ischaemic heart disease than for cerebrovascular stroke.
In 1982 mortality from ischaemic heart disease in North Karelian women was for the first time below the national average. Mortality from all cardiovascular diseases in North Karelian women declined very steeply from 1972, by about 6-00/o a year, and approached the national average in 1982. The downward trend in mortality from ischaemic heart disease and cardiovascular disease seemed to take place during the entire period of the study, though we must be cautious about interpreting trends over shorter periods, especially in small numbers of women. An increasing trend in mortality from stroke was seen in North Karelian women from 1977 to 1981. This has been associated with some relapses in drug treatment of hypertensive women during this period.2' Finally, we may ask whether the greater decline in mortality from ischaemic heart disease and cardiovascular disease in North Karelia, as well as the lesser decline in the rest of the country, really was due to changes in risk factors. Our analysis was not based on a trial, but the decline in both North Karelia and the whole country seems to agree with the information available on changes in risk factors. The greater decline in mortality from ischaemic heart disease in North Karelia is also in accord with the greater change in risk factors in that province than in the rest of Finland' 7 23-25 (A Nissinen et al, unpublished). This difference in the change in risk factors is attributed to the comprehensive intervention carried out in North Karelia since 1972, though the matter is further complicated because intervention in North Karelia has also influenced development in the whole. country, especially since 1977 after the first five years ofthe project. As we cannot think ofany reason for the greater decline of mortality from ischaemic heart disease in North Karelia other than the prevention programme it is reasonable to argue that it was a consequence of the project. Although mortality in 1%9 to 1971 in North Karelia was the highest among the Finnish provinces, a review of the changing trends in all provinces indicates that the regression to the mean explains neither the greater decline in North Karelia nor differences in the decline between different areas of Finland.9
To conclude, this analysis of cardiovascular mortality in North Karelia shows a favourable trend over the past 14 years. Furthermore, cardiovascular mortality seems to have decreased more in North Karelia than in the rest of Finland. The North Karelia project has probably had a great influence on this recent favourable development in Finland, especially in the study area of North Karelia.
